Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG and DIPG
Clinical trial NCT07644312 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07644312
- Sponsor
- Nationwide Children's Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2027-03-01
- Primary completion
- 2033-03-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.